FDA Inspection 1216440 — Federico C. Perez Manghi, MD
The FDA completed an inspection of Federico C. Perez Manghi, MD on August 25, 2023 in Ciudad Autonoma Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)